What the Future Holds for Informed Consent

April 2, 2018 Mika Lindroos

Mika Lindroos, Director of Product Management at CRF Health, discusses the advantages of electronic informed consent in clinical trials and how by integrating this process with eCOA technologies, researchers can reduce burden for study teams, decrease regulatory risk, increase participant comprehension, and improve overall study outcomes. Courtesy of PharmaFocus (original link: http://edition.pagesuite-professional.co.uk/launch.aspx?eid=b3114258-2357-4dee-b791-295cd1220624&pnum=18)

About the Author

Mika Lindroos

Director of Product Management, CRF Health

More Content by Mika Lindroos
Previous Article
Preparing for eConsent - A Step by Step Guide for Site Personnel
Preparing for eConsent - A Step by Step Guide for Site Personnel

5 steps to help sites prepare for implementing an electronic informed consent (eConsent) solution.

Next Article
eConsent Myth #2: The process of creating and executing informed consent is not improved with eConsent
eConsent Myth #2: The process of creating and executing informed consent is not improved with eConsent